# NSG Ventures

> NSG Ventures is a VC fund in Singapore backing Biopharma, Biotechnology and Software. See 3 investments, round sizes, portfolio. Updated Aug 2026.

- Type: VC Fund
- Location: Singapore, Singapore
- Total investments: 3
- Last investment: Jan 2024
- Lead investor: 0%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/company/nsg-ventures
- Website: https://nsg.ventures

NSG Ventures is a biotech venture capital firm.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Biopharma | 2 | 67% |
| Biotechnology | 2 | 67% |
| Software | 1 | 33% |
| Health Care | 1 | 33% |
| Manufacturing | 1 | 33% |

12 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Seed | 1 | 33% |
| Series A | 1 | 33% |
| Venture - Series Unknown | 1 | 33% |

### Country

| Country | Investments | Share |
| --- | --- | --- |
| Singapore | 1 | 33% |
| South Korea | 1 | 33% |
| United States | 1 | 33% |

## Investments

| Company | Description | Round size | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| GDMC | GDMC is a pharmaceutical company that engages in manufacturing and designing genetic medicines. | $21M | Series A | Jan 24, 2024 |  |
| Lunit | Lunit, abbreviated from “learning unit,” is a venture company devoted to developing advanced software for medical data analysis and interpretation via cutting-edge deep learning technology. The company's main area of expertise lies in processing medical imaging data. It envisions a near future when its systems will greatly help physicians makeaccurate, consistent, and efficient clinical decisions, not limited to diagnoses, through our data-driven imaging biomarker technology. The high level of our deep learning technology has been well demonstrated, ranked top 5 at ImageNet Challenge 2015, which is the world’s largest and most prestigious image recognition competition. What distinguishes our technology from that of other similar parties is the full accommodation of weakly labeled data, challenging the boundaries of human understanding in terms of pattern recognition. | $61M | Venture - Series Unknown | Nov 29, 2021 |  |
| Protuoso Biosciences | Protuoso Biosciences is a biotechnology company developing next-generation multifunctional biologics designed to address complex disease biology. | $9.5M | Seed |  |  |

3 of 3 investments shown.

## Co-investors
- [Seeds Capital](https://shizune.co/investors/profile/seeds-capital) — VC Fund, 2 deals together
- [Casdin Capital](https://shizune.co/investors/profile/casdin-capital) — VC Fund, 1 deal together
- [Celadon Partners](https://shizune.co/investors/profile/celadon-partners) — VC Fund, 1 deal together
- [Darwin Ventures](https://shizune.co/investors/profile/darwin-ventures) — VC Fund, 1 deal together
- [HealthQuest Capital](https://shizune.co/investors/profile/heathquest-capital-2) — VC Fund, 1 deal together
- [IMM Investment](https://shizune.co/investors/profile/imm-investment) — VC Fund, 1 deal together

## Similar investors

### Similar industry
- [SOSV](https://shizune.co/investors/profile/sosv) — VC Fund
- [ARCH Venture Partners](https://shizune.co/investors/profile/arch-venture-partners) — VC Fund
- [OrbiMed](https://shizune.co/investors/profile/orbimed-advisors) — VC Fund

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

### Similar country
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Seeds Capital](https://shizune.co/investors/profile/seeds-capital) — VC Fund
- [Wavemaker Ventures](https://shizune.co/investors/profile/wavemaker-partners) — VC Fund

## Featured in investor lists
- [Manufacturing Investors in Singapore](https://shizune.co/investors/manufacturing-investors-singapore)
- [Manufacturing VC Funds in Singapore](https://shizune.co/investors/manufacturing-vc-funds-singapore)
- [Biotechnology VC Funds in Singapore](https://shizune.co/investors/biotechnology-vc-funds-singapore)
- [Biotech VC Funds in Singapore](https://shizune.co/investors/biotech-vc-funds-singapore)
- [Biotechnology Investors in Singapore](https://shizune.co/investors/biotechnology-investors-singapore)

## FAQ

### What does NSG Ventures invest in?

NSG Ventures invests primarily in Biopharma, Biotechnology and Software startups, most often at Seed and Series A stage. Most of the 3 investments tracked by Shizune back companies in Singapore. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did NSG Ventures last invest?

The most recent investment recorded for NSG Ventures closed in Jan 2024. Shizune tracks 3 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co